Page last updated: 2024-11-07

androsterone and Myasthenia Gravis

androsterone has been researched along with Myasthenia Gravis in 1 studies

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Papatestas, AE1
Mulvihill, M1
Genkins, G1
Kornfeld, P1
Aufses, AH1
Wang, DY1
Bulbrook, RD1

Other Studies

1 other study available for androsterone and Myasthenia Gravis

ArticleYear
Thymus and breast cancer--plasma androgens, thymic pathology, and peripheral lymphocytes in myasthenia gravis.
    Journal of the National Cancer Institute, 1977, Volume: 59, Issue:6

    Topics: Adult; Androgens; Androsterone; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Leukocyte

1977